Merck & Co., Inc.
LSE: 0QAH.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Robert Davis
- Employees
- 73,000
- Headquarters
- Kenilworth, United States
- IPO year
- 2006
- Market cap
- $281.1B
- Website
- https://www.merck.com
Loading 0QAH…
Loading profile data…Frequently asked questions about 0QAH
What does Merck & Co., Inc. (0QAH.L) do?
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such...
Where does 0QAH.L trade?
Merck & Co., Inc. (0QAH.L) trades on the London Stock Exchange.
What sector is 0QAH.L in?
Merck & Co., Inc. (0QAH.L) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Merck & Co., Inc.?
Robert Davis is the chief executive officer of Merck & Co., Inc. (0QAH.L).
Where is Merck & Co., Inc. headquartered?
Merck & Co., Inc. is headquartered in United States.
Does 0QAH.L pay a dividend?
Yes — Merck & Co., Inc. (0QAH.L) paid a trailing twelve-month dividend of USD 3.32 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0QAH.L go public?
Merck & Co., Inc. (0QAH.L) completed its initial public offering in 2006.